Coating suitable for medicament contact
View Patent ↗A coating composition is provided that is suitable for use on a medicament-contact surface. The coating composition preferably includes one or more acrylic-containing polymer and a carrier. In preferred embodiments, the coating composition is an aqueous dispersion or solution.
1. A coated article, comprising:
a pressurized metered dose inhaler, comprising:
a pressurized container filled with a propellant-based medicament composition including a drug and a liquefied gas propellant, wherein the pressurized container has a coating applied on at least a portion of an interior metal surface such that the coating is in contact with the medicament composition; and
wherein the coating is formed from an aqueous coating composition that comprises a water-dispersible resin system that includes at least about 10% by weight, based on total solids, of an emulsion polymerized acrylic latex polymer, and wherein the aqueous coating composition is substantially free of bound BPA and aromatic glycidyl ether compounds.
2. The coated article of claim 1 , wherein the liquefied gas propellant comprises a hydrofluoroalkane, a chlorofluorocarbon, a hydrofluorocarbon, or a combination thereof.
3. The coated article of claim 1 , wherein the interior metal surface comprises aluminum.
4. The coated article of claim 1 , wherein the resin system, based on total solids, comprises from about 50% to about 100% by weight of acrylic.
5. The coated article of claim 1 , wherein the emulsion polymerized acrylic latex polymer comprises a reaction product of ethylenically unsaturated acid or anhydride monomers.
6. The coated article of claim 1 , wherein the coating composition further comprises a co-resin selected from a polyester polymer, a fluoropolymer, an epoxy polymer, a phenolic resin, a vinyl chloride polymer, an acrylic polymer, or a combination thereof.
7. The coated article of claim 1 , wherein the emulsion polymerized latex polymer comprises a reaction product of reactants including:
(i) an acid- or anhydride-functional acrylic polymer;
(ii) a mixture of ethylenically unsaturated monomers including at least one oxirane-functional monomer; and
(iii) an amine.
8. The coated article of claim 1 , wherein the emulsion polymerized acrylic latex polymer includes an acrylic component formed from an acrylic monomer mixture including a (meth)acrylic acid ester, an ethylenically unsaturated mono- or multi-functional acid or anhydride, and a vinyl compound.
9. The coated article of claim 8 , wherein the acrylic monomer mixture includes an acrylic and/or methacrylic acid, styrene, and ethyl acrylate.
10. The coated article of claim 1 , wherein the medicament comprises albuterol, salmeterol, or budesonide.
11. The coated article of claim 10 , wherein the liquefied gas propellant comprises a hydrofluoroalkane, a chlorofluorocarbon, a hydrofluorocarbon, or a combination thereof.
12. The coated article of claim 1 , wherein the metal can comprises a deep drawn metal can, and wherein the coating has an average coating thickness of from 1 to 30 microns.
13. The coated article of claim 1 , wherein the coating is a monolayer coating having an average coating thickness of from about 10 to about 20 microns.
14. The coated article of claim 1 , wherein:
the aqueous coating composition includes from at least 10 to less than 50 weight percent of solids, based on the total weight of the coating composition; and
water constitutes at least 50 weight percent of the liquid carrier system of the aqueous coating composition.
15. The coated article of claim 1 , wherein the water-dispersible resin system includes about 75 weight percent to about 100 weight percent of the emulsion polymerized acrylic latex polymer, by weight of the total solids of the resin system.
16. The coated article of claim 1 , wherein the water-dispersible resin system includes a fluoropolymer co-resin.
17. A coated article, comprising:
a pressurized metered dose inhaler, comprising:
a pressurized metal can having a coating that is substantially free of bound BPA and aromatic glycidyl ether compounds applied on at least a portion of an interior surface, wherein the coating is formed from an aqueous coating composition comprising a water-dispersible resin system that includes about 75 weight percent to about 100 weight percent of an emulsion polymerized acrylic latex polymer, by weight of the total solids of the resin system; wherein the pressurized metal can contains a medicament composition including:
a medicament that is a pulmonary or nasal medicament,
a liquefied gas propellant.
18. The coated article of claim 17 , wherein the liquefied gas propellant comprises a hydrofluoroalkane, a chlorofluorocarbon, a hydrofluorocarbon, or a combination thereof.
19. The coated article of claim 18 , wherein the coating is a monolayer coating having an average coating thickness of from about 10 to about 20 microns.
20. A method, comprising:
providing a metered dose inhaler container comprising:
a metallic interior surface, and
an adherent polymer coating that is substantially free of bound BPA and aromatic glycidyl ether compounds applied to the metallic interior surface, the adherent polymer coating formed from an aqueous coating composition comprising a water-dispersible resin system that includes at least about 10% by weight, based on total solids, of an emulsion polymerized acrylic latex polymer; and
filling the container with a medicament composition including a medicament and a liquefied gas propellant so that the medicament composition is in contact with the adherent polymer coating.
21. The method of claim 20 , wherein the liquefied gas propellant comprises a hydrofluoroalkane, a chlorofluorocarbon, a hydrofluorocarbon, or a combination thereof, and wherein the coating has an average coating thickness of from about 1 to about 30 microns.